Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4261 results

Sort By:

Addressing Food Insecurity: Plant-Based Food Prescription Program

Study ID: NCT06614920
Start Date: 2025-01-09
End Date: 2026-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Plant-Based Food Provision (with or without food prescription)

Plant-Based Nutrition Education

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer

Study ID: NCT06658782
Start Date: 2024-12-01
End Date: 2039-04-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

non contrast enhanced MRI

Sponsor

University of Oxford

Source: clinicaltrials.gov

Share:
Add to list

Combined Use of PRP and Hyaluronic Acid for Infiltrative Treatment of Patients With Knee Osteoarthritis

Study ID: NCT06685120
Start Date: 2025-01
End Date: 2029-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

288

Intervention / Treatment

PRP + HA injection

PRP injection

HA injection

Sponsor

Rizzoli Orthopedic Institute

Source: clinicaltrials.gov

Share:
Add to list

A Prospective Evaluation of Colorado's New Statutory PDMP Mandates: Compliance and Patient Outcomes

Study ID: NCT06215560
Start Date: 2024-12
End Date: 2026-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

70000

Intervention / Treatment

PDMP Check CDS

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Choline and Iron Deficiency

Study ID: NCT06527391
Start Date: 2024-12-02
End Date: 2027-04-21
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

choline bitartrate

placebo drug

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Anatomical and Functional Predictions of Blindsight Abilities in Patients With Homonymous Lateral Hemianopsia

Study ID: NCT06636994
Start Date: 2025-06-01
End Date: 2029-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

Adolphe de Rothschild Ophthalmological Foundation

Source: clinicaltrials.gov

Share:
Add to list

Bridging the Treatment Gap by Expanding Access to Care for People with Epilepsy in Kenya (BEACON)

Study ID: NCT06623994
Start Date: 2025-06
End Date: 2029-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

530

Intervention / Treatment

Task sharing with Epilepsy Medical Record Systems

Sponsor

Indiana University

Source: clinicaltrials.gov

Share:
Add to list

Silver Nitrate Vs. Triamcinolone for Treatment of Hypergranulation Tissue

Study ID: NCT06681194
Start Date: 2025-01-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

270

Intervention / Treatment

Silver Nitrate

triamcinolone

Silver nitrate + triamcinolone

Sponsor

Francesco Egro

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants

Study ID: NCT06655194
Start Date: 2025-02-10
End Date: 2025-03-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

38

Intervention / Treatment

Acetylsalicylic Acid (Aspirin, BAYE004465, UI1610477)

Acetylsalicylic Acid (BAYE004465, UI1615160)

Sponsor

Bayer

Source: clinicaltrials.gov

Share:
Add to list

Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS

Study ID: NCT06692491
Start Date: 2025-01-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Albumin-Bound Paclitaxel

Epirubicin

Gemcitabine

Vinorelbine

Cisplatin

Irinotecan

Fluorouracil

Nivolumab

Pembrolizumab

Durvalumab

Atezolizumab

Shintilimab

Tislelizumab

Camrelizumab

triplimab

Serplulimab

Adebrelimab

envafolimab

Osimertinib

Alectinib

Vemurafenib

On the sidelines

Pyrotinib

Imatinib

Palbociclib

I asked

Entrectinib

Other

Sponsor

Peking University Shenzhen Hospital

Source: clinicaltrials.gov

Share:
Add to list